A Clinical Study of Tobradex AF


The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double
  • Study Primary Completion Date: February 2007


  • Drug: Tobradex AF

Clinical Trial Outcome Measures

Primary Measures

  • Concentration of dexamethasone in aqueous humor following a single topical ocular administration
    • Time Frame: Periodic

Secondary Measures

  • Changes in external and internal ocular structures, intraocular pressure, vision and other side effects
    • Time Frame: Periodic

Participating in This Clinical Trial

Inclusion Criteria

  • Adult patients requiring cataract surgery

Exclusion Criteria

  • Age related

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Alcon Research
  • Overall Official(s)
    • Robert Faulkner, Study Director, Alcon Research

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.